ARS Pharmaceuticals, Inc. (SPRY)

CIK 1671858 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ARS Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001193125-26-449748
Nov 5, 202610-Q0001193125-26-449778
Nov 4, 202640001475990-26-000009
Nov 4, 202630001475990-26-000008
Oct 30, 20261440001950047-26-010513
Oct 19, 20261440001950047-26-010301
Oct 5, 202640002135296-26-000009
Oct 1, 20261440001950047-26-009969
Sep 30, 20261440001950047-26-009892
Sep 11, 20261440001950047-26-009329
Sep 11, 20261440001950047-26-009340
Sep 4, 20261440001950047-26-009120
Sep 3, 20261440001950047-26-009066
Sep 2, 20261440001950047-26-009041
Sep 2, 202640002149973-26-000004
Sep 1, 20261440001950047-26-008961
Aug 31, 20261440001950047-26-008852
Aug 20, 20261440001950047-26-008488
Aug 20, 20261440001950047-26-008459
Aug 19, 20261440001950047-26-008389
Aug 19, 20261440001950047-26-008376
Aug 18, 20261440001950047-26-008357
Aug 18, 20261440001950047-26-008362
Aug 17, 202630002149973-26-000002
Aug 13, 202610-Q0001193125-26-349140